Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study)

International Retina Biosimilar Study Group (Inter BIOS Group)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)3193-3196
Number of pages4
JournalEye (Basingstoke)
Volume38
Issue number16
DOIs
StatePublished - 2024/11

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this